Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 467
Immune Disorders Drugs 194
Cardiovascular Drugs 156
Biopharmaceuticals 133
Infectious Diseases Drugs 124
Drug Discovery 107
Central Nervous System Drugs 106
Endocrine and Metabolic Disorders Drugs 103
Clinical Trials 98
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 89
Leukemia Drugs 83
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 65
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Respiratory Drugs 39
Immunosuppressive Drugs 37
Gastrointestinal Drugs 33
Infusions and Injectables 32
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Pharmaceutical Manufacturing 28
Bladder Cancer Drugs 26
Analgesics 26
Drugs by Therapeutic Area 24
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Prostate Cancer Drugs 17
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Urological Disorders Drugs 16
Schizophrenia Drugs 16
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Vitamins and Dietary Supplements 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

2,397 Results (Page 32 of 120)
- Relevance
  Sort by

Thyroid Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4184EUR$4,750USD£3,677GBP

Psoriatic Arthritis Treatment Market Report 2025

 Report
April 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Organ Transplant Immunosuppressant Drugs Market - Growth, Trends, and Forecasts (2023-2028)

 Report
April 2023
114 Pages
Global

From

€4184EUR$4,750USD£3,677GBP

Natural Killer Cells Therapeutics Market Report by Therapeutics, Application, End User, and Region 2025-2033

 Report
September 2025
149 Pages
Global

From

€2245EUR$2,549USD£1,974GBP

€2641EUR$2,999USD£2,322GBP

Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

 Report
November 2023
175 Pages
Global

From

€5240EUR$5,950USD£4,606GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Axial Spondyloarthritis (AxSpA) Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Psoriatic Arthritis - Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1409EUR$1,600USD£1,239GBP

€1762EUR$2,000USD£1,548GBP

Cardiovascular Clinical Trials Market Analysis & Forecast to 2024-2034

 Report
January 2024
200 Pages
Global

From

€3655EUR$4,150USD£3,213GBP

Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Systemic Lupus Erythematosus - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2114EUR$2,400USD£1,858GBP

€2642EUR$3,000USD£2,323GBP

Hepatocellular Carcinoma - Global Clinical Trials Review, 2023

 Clinical Trials
December 2023
2557 Pages
Global

From

€2202EUR$2,500USD£1,935GBP

Duchenne Muscular Dystrophy Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3955EUR$4,490USD£3,476GBP

Antiviral Drugs Market - Global Forecast 2025-2032

 Report
October 2025
190 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€5602EUR$6,360USD£4,924GBP

€7002EUR$7,950USD£6,155GBP

Ulcerative Colitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2114EUR$2,400USD£1,858GBP

€2642EUR$3,000USD£2,323GBP

Rheumatoid Arthritis Drugs Market by Drug Class, Route of Administration, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2027

 Report
July 2023
200 Pages
Global

From

€3963EUR$4,500USD£3,484GBP

Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027

 Report
July 2023
218 Pages
Global

From

€3963EUR$4,500USD£3,484GBP

Foscarnet Sodium Market - Global Forecast 2025-2030

 Report
August 2025
180 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Direct Acting Antivirals Market - Global Forecast 2025-2030

 Report
August 2025
193 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

Cryptococcosis Market - Global Forecast 2025-2032

 Report
October 2025
188 Pages
Global

From

€3122EUR$3,545USD£2,745GBP

€3469EUR$3,939USD£3,050GBP

2,397 Results (Page 32 of 120)
- 1
- 30
- 31
- 32
- 33
- 34

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.